Amy Jessop, PHD, MPH, is Director of Research and HepTREC. Dr. Jessop has extensive experience designing and conducting community-based research and service projects. Prior to joining HepTREC at PPP, she served on PPP’s Board of Directors for more than 15 years and developed its Research Committee. She also served on or chaired IRB committees within several universities. These experiences may be helpful to external researchers as they plan projects with PPP.

Dr. Jessop’s research has been concerned with adult immunization, viral hepatitis prevention and treatment, and adaption and implementation of prevention and care guidelines. She received her BS in Microbiology from Penn State, and MPH in Epidemiology/Quantitative Methods from UMDNJ/RWJ Medical School, and PhD in Health Studies from Temple University.

Rachel Holbert, MPA, MPH, is HepTREC’s Health Equity Research Specialist. She is an experienced evaluator and project manager, specializing in health, education, and human services programs. Previously, she served as the evaluator of Delaware’s CDC-funded Overdose Data to Action grant, where she worked with the State to develop and monitor indicators and progress toward prevention, response, and surveillance goals. She has also served as an evaluation consultant to numerous organizations.

As part of her Temple University MPH fieldwork completed in Spring 2021, Ms. Holbert recruited and interviewed women who inject drugs and use services at Prevention Point Philadelphia for an intervention study designed to improve PrEP uptake and adherence. In addition to her Temple University MPH, Ms. Holbert also has a Master’s in Public Administration from Syracuse University.